Protara Therapeutics Inc.

NASDAQ: TARA · Real-Time Price · USD
3.14
-0.01 (-0.32%)
At close: May 29, 2025, 2:31 PM
-0.32%
Bid 3.11
Market Cap 121.15M
Revenue (ttm) n/a
Net Income (ttm) -45.41M
EPS (ttm) -1.49
PE Ratio (ttm) -2.11
Forward PE -1.85
Analyst Buy
Ask 3.19
Volume 93,121
Avg. Volume (20D) 354,227
Open 3.17
Previous Close 3.15
Day's Range 3.13 - 3.19
52-Week Range 1.59 - 10.48
Beta 1.72

About TARA

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TARA
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for TARA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
1 month ago
-18.52%
Protara Therapeutics shares are trading lower. The... Unlock content with Pro Subscription
1 month ago
+6.6%
Protara Therapeutics shares are trading higher after the company announced it will review the interim data from its Phase 2 ADVANCED-2 trial.